179 related articles for article (PubMed ID: 37149721)
21. CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
Timpanaro A; Piccand C; Dzhumashev D; Anton-Joseph S; Robbi A; Moser J; Rössler J; Bernasconi M
J Exp Clin Cancer Res; 2023 Nov; 42(1):293. PubMed ID: 37924157
[TBL] [Abstract][Full Text] [Related]
22. Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
Zhang X; Guo H; Chen J; Xu C; Wang L; Ke Y; Gao Y; Zhang B; Zhu J
Cancer Lett; 2023 Sep; 572():216355. PubMed ID: 37597651
[TBL] [Abstract][Full Text] [Related]
23. B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
Zhang S; Black RG; Kohli K; Hayes BJ; Miller C; Koehne A; Schroeder BA; Abrams K; Schulte BC; Alexiev BA; Heimberger AB; Zhang A; Jing W; Ng JCK; Shinglot H; Seguin B; Salter AI; Riddell SR; Jensen MC; Gottschalk S; Moore PF; Torok-Storb B; Pollack SM
Mol Cancer Ther; 2022 Jun; 21(6):999-1009. PubMed ID: 35405743
[TBL] [Abstract][Full Text] [Related]
24. Case report: B7-H3 CAR-T therapy partially controls tumor growth in a basal cell carcinoma patient.
Hu G; Li G; Wen W; Ding W; Zhou Z; Zheng Y; Huang T; Ren J; Chen R; Zhu D; He R; Liang Y; Luo M
Front Oncol; 2022; 12():956593. PubMed ID: 36059640
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma.
Tang X; Zhao S; Zhang Y; Wang Y; Zhang Z; Yang M; Zhu Y; Zhang G; Guo G; Tong A; Zhou L
Mol Ther Oncolytics; 2019 Sep; 14():279-287. PubMed ID: 31485480
[TBL] [Abstract][Full Text] [Related]
26. B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma.
Long C; Li G; Zhang C; Jiang T; Li Y; Duan X; Zhong G
Front Oncol; 2021; 11():659662. PubMed ID: 34868903
[TBL] [Abstract][Full Text] [Related]
27. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer.
Yang S; Cao B; Zhou G; Zhu L; Wang L; Zhang L; Kwok HF; Zhang Z; Zhao Q
Front Pharmacol; 2020; 11():1089. PubMed ID: 32848731
[TBL] [Abstract][Full Text] [Related]
28. B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers.
Ventin M; Cattaneo G; Maggs L; Jia J; Arya S; Ferrone S; Wang X; Ferrone CR
Front Oncol; 2023; 13():1193963. PubMed ID: 37483496
[TBL] [Abstract][Full Text] [Related]
29. A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy.
Zhang Z; Wang G; Zhong K; Chen Y; Yang N; Lu Q; Yuan B; Wang Z; Li H; Guo L; Zhang R; Wu Z; Zheng M; Zhao S; Tang X; Shao B; Tong A
J Transl Med; 2023 Jan; 21(1):23. PubMed ID: 36635683
[TBL] [Abstract][Full Text] [Related]
30. B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma.
Zi Z; Zhao H; Wang H; Ma X; Wei F
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348781
[TBL] [Abstract][Full Text] [Related]
31. A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells.
Talbot LJ; Chabot A; Funk A; Nguyen P; Wagner J; Ross A; Tillman H; Davidoff A; Gottschalk S; DeRenzo C
Front Immunol; 2021; 12():691741. PubMed ID: 34211478
[TBL] [Abstract][Full Text] [Related]
32. Targeting B7-H3-A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment.
Rasic P; Jeremic M; Jeremic R; Dusanovic Pjevic M; Rasic M; Djuricic SM; Milickovic M; Vukadin M; Mijovic T; Savic D
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110590
[TBL] [Abstract][Full Text] [Related]
33. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
Theruvath J; Sotillo E; Mount CW; Graef CM; Delaidelli A; Heitzeneder S; Labanieh L; Dhingra S; Leruste A; Majzner RG; Xu P; Mueller S; Yecies DW; Finetti MA; Williamson D; Johann PD; Kool M; Pfister S; Hasselblatt M; Frühwald MC; Delattre O; Surdez D; Bourdeaut F; Puget S; Zaidi S; Mitra SS; Cheshier S; Sorensen PH; Monje M; Mackall CL
Nat Med; 2020 May; 26(5):712-719. PubMed ID: 32341579
[TBL] [Abstract][Full Text] [Related]
34. Chimeric Antigen Receptor T Cell with an Inducible Caspase 9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.
Ventin M; Cattaneo G; Arya S; Jia J; Gelmi MC; Sun Y; Maggs L; Ksander BR; Verdijk RM; Boland GM; Jenkins RW; Haq R; Jager MJ; Wang X; Ryeom S; Ferrone CR
Clin Cancer Res; 2024 May; ():. PubMed ID: 38767611
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma.
Zheng M; Yu L; Hu J; Zhang Z; Wang H; Lu D; Tang X; Huang J; Zhong K; Wang Z; Li Y; Guo G; Liu S; Tong A; Yang H
Transl Oncol; 2020 May; 13(5):100770. PubMed ID: 32298986
[TBL] [Abstract][Full Text] [Related]
36. B7-H3: An Attractive Target for Antibody-based Immunotherapy.
Kontos F; Michelakos T; Kurokawa T; Sadagopan A; Schwab JH; Ferrone CR; Ferrone S
Clin Cancer Res; 2021 Mar; 27(5):1227-1235. PubMed ID: 33051306
[TBL] [Abstract][Full Text] [Related]
37. PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo.
Liao Q; Mao Y; He H; Ding X; Zhang X; Xu J
Biomark Res; 2020 Nov; 8(1):57. PubMed ID: 33292688
[TBL] [Abstract][Full Text] [Related]
38. An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo.
Zhang T; Wu MR; Sentman CL
J Immunol; 2012 Sep; 189(5):2290-9. PubMed ID: 22851709
[TBL] [Abstract][Full Text] [Related]
39. Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours.
Li D; Wang R; Liang T; Ren H; Park C; Tai CH; Ni W; Zhou J; Mackay S; Edmondson E; Khan J; Croix BS; Ho M
Nat Commun; 2023 Sep; 14(1):5920. PubMed ID: 37739951
[TBL] [Abstract][Full Text] [Related]
40. Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy.
Zhu L; Liu J; Zhou G; Liu TM; Dai Y; Nie G; Zhao Q
Small; 2021 Oct; 17(43):e2102624. PubMed ID: 34378338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]